Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Chinese Patent Office
McKesson
Fuji
Cantor Fitzgerald
Harvard Business School
Medtronic
Queensland Health
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Atovaquone - Generic Drug Details

« Back to Dashboard

What are the generic sources for atovaquone and what is the scope of atovaquone patent protection?

Atovaquone
is the generic ingredient in five branded drugs marketed by Amneal Pharms, Apotex Inc, Paddock Llc, Glaxosmithkline Llc, Glenmark Generics, Mylan Pharms Inc, and Glaxosmithkline, and is included in eight NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atovaquone. Three suppliers are listed for this compound.

Pharmacology for atovaquone

Medical Subject Heading (MeSH) Categories for atovaquone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Glenmark GenericsATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL091211-002Apr 6, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncATOVAQUONEatovaquoneSUSPENSION;ORAL209750-001Oct 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL202362-002May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Paddock LlcATOVAQUONEatovaquoneSUSPENSION;ORAL207833-001Apr 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsATOVAQUONEatovaquoneSUSPENSION;ORAL202960-001Mar 18, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneSUSPENSION;ORAL020500-001Feb 8, 1995ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mylan Pharms IncATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL202362-001May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark GenericsATOVAQUONE AND PROGUANIL HYDROCHLORIDEatovaquone; proguanil hydrochlorideTABLET;ORAL091211-001Jan 12, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineMALARONE PEDIATRICatovaquone; proguanil hydrochlorideTABLET;ORAL021078-002Jul 14, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneTABLET;ORAL020259-001Nov 25, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atovaquone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline LlcMEPRONatovaquoneSUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneTABLET;ORAL020259-001Nov 25, 1992► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneTABLET;ORAL020259-001Nov 25, 1992► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneSUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
Glaxosmithkline LlcMEPRONatovaquoneSUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
QuintilesIMS
Dow
Citi
Teva
Novartis
AstraZeneca
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot